The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
The Role of PD-1 in Acute and Chronic Infection
Open accessAbstract
PD-1 as an immune checkpoint molecule down-regulates T cell activity during immune responses in order to prevent autoimmune tissue damage. In chronic infections or tumors, lasting antigen-exposure leads to permanent PD-1 expression that can limit immune-mediated clearance of pathogens or degenerated cells. Blocking PD-1 can enhance T cell function; in cancer treatment PD-1 blockade is already used as a successful therapy. However, the role of PD-1 expression and blocking in the context of acute and chronic infections is less defined. Building on its success in cancer therapy leads to the hypothesis that blocking PD-1 in infectious diseases is also beneficial in acute or chronic infections. This review will focus on the role of PD-1 expression in acute and chronic infections with virus, bacteria, and parasites, with a particular focus on recent studies regarding PD-1 blockade in infectious diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
Marshall, B., & Warren, J. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91816-6 · Cited by 5,509
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Ishida, Y., Agata, Y., Shibahara, K., & Honjo, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05481.x · Cited by 3,256
Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T., & Minato, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192461099 · Cited by 3,203
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,079
Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062
The diverse functions of the PD1 inhibitory pathway
Sharpe, A. H., & Pauken, K. E. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.108 · Cited by 1,971
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Sharpe, A. H., Wherry, E. J., Ahmed, R., & Freeman, G. J. (2007) · Nature Immunology · doi:10.1038/ni1443 · Cited by 1,528
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475
Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., & Riley, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.945 · Cited by 1,246
Patsoukis, N., Bardhan, K., Chatterjee, P., Sari, D., Liu, B., Bell, L. N., Karoly, E. D., Freeman, G. J., Petkova, V., Seth, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms7692 · Cited by 1,202
Yokosuka, T., Takamatsu, M., Kobayashi-Imanishi, W., Hashimoto-Tane, A., Azuma, M., & Saito, T. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112741 · Cited by 1,161 · cited 1×
“The downstream effects of PD-1 signaling include inhibition of AKT, phosphoinositide 3-kinase (PI3K), extracellular-signal regulated kinase (ERK), and phosphoinositide phospholipase C-γ (PLCγ) and regulation of the cell cycle leading to decreased IFN-γ/IL-2 production, reduced proliferation potential, and increased ri…”
BackgroundT-cell exhaustion in the tumor microenvironment
Jiang, Y., Li, Y., & Zhu, B. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.162 · Cited by 1,157
Expression of Programmed Death 1 Ligands by Murine T Cells and APC
Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T., Tsuchiya, H., Pardoll, D. M., Okumura, K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5538 · Cited by 951
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920
Coinhibitory Pathways in Immunotherapy for Cancer
Baumeister, S. H., Freeman, G. J., Dranoff, G., & Sharpe, A. H. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112049 · Cited by 910
Progenitor and Terminal Subsets of CD8 + T Cells Cooperate to Contain Chronic Viral Infection
Paley, M. A., Kroy, D. C., Odorizzi, P. M., Johnnidis, J. B., Dolfi, D. V., Barnett, B. E., Bikoff, E. K., Robertson, E. J., Lauer, G. M., Reiner, S. L., et al. (2012) · Science · doi:10.1126/science.1229620 · Cited by 902
Sheppard, K.-A., Fitz, L. J., Lee, J. M., Benander, C., George, J. A., Wooters, J., Qiu, Y., Jussif, J. M., Carter, L. L., Wood, C. R., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.083 · Cited by 791
Enhancing SIV-specific immunity in vivo by PD-1 blockade
Velu, V., Titanji, K., Zhu, B., Husain, S., Pladevega, A., Lai, L., Vanderford, T. H., Chennareddi, L., Silvestri, G., Freeman, G. J., et al. (2009) · Nature · doi:10.1038/nature07662 · Cited by 771
Bauquet, A. T., Jin, H., Paterson, A. M., Mitsdoerffer, M., Ho, I.-C., Sharpe, A. H., & Kuchroo, V. K. (2009) · Nature Immunology · doi:10.1038/ni.1690 · Cited by 713
OX40 Promotes Bcl-xL and Bcl-2 Expression and Is Essential for Long-Term Survival of CD4 T Cells
Rogers, P. R., Song, J., Gramaglia, I., Killeen, N., & Croft, M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00191-1 · Cited by 646
Blank, C., Gajewski, T. F., & Mackensen, A. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0593-x · Cited by 637
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
Schildberg, F. A., Klein, S. R., Freeman, G. J., & Sharpe, A. H. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.002 · Cited by 542
Self-citationImmune checkpoints and their inhibition in cancer and infectious diseases
Dyck, L., & Mills, K. H. G. (2017) · European Journal of Immunology · doi:10.1002/eji.201646875 · Cited by 541
Huang, X., Venet, F., Wang, Y. L., Lepape, A., Yuan, Z., Chen, Y., Swan, R., Kherouf, H., Monneret, G., Chung, C.-S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809422106 · Cited by 515
Fisicaro, P., Valdatta, C., Massari, M., Loggi, E., Biasini, E., Sacchelli, L., Cavallo, M. C., Silini, E. M., Andreone, P., Missale, G., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.052 · Cited by 488
Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection
Butler, N. S., Moebius, J., Pewe, L. L., Traore, B., Doumbo, O. K., Tygrett, L. T., Waldschmidt, T. J., Crompton, P. D., & Harty, J. T. (2012) · Nature Immunology · doi:10.1038/ni.2180 · Cited by 482
Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells
Odorizzi, P. M., Pauken, K. E., Paley, M. A., Sharpe, A., & Wherry, E. J. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142237 · Cited by 467
Strauss, L., Bergmann, C., Szczepanski, M., Gooding, W., Johnson, J. T., & Whiteside, T. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0472 · Cited by 453
A critical role for the programmed death ligand 1 in fetomaternal tolerance
Guleria, I., Khosroshahi, A., Ansari, M. J., Habicht, A., Azuma, M., Yagita, H., Noelle, R. J., Coyle, A., Mellor, A. L., Khoury, S. J., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050019 · Cited by 439
The late phase of sepsis is characterized by an increased microbiological burden and death rate
Otto, G. P., Sossdorf, M., Claus, R. A., Rödel, J., Menge, K., Reinhart, K., Bauer, M., & Riedemann, N. C. (2011) · Critical Care · doi:10.1186/cc10332 · Cited by 434
Aandahl, E. M., Michaëlsson, J., Moretto, W. J., Hecht, F. M., & Nixon, D. F. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2454-2459.2004 · Cited by 428
Treatment of Hepatitis C: A Systematic Review
Kohli, A., Shaffer, A., Sherman, A., & Kottilil, S. (2014) · JAMA · doi:10.1001/jama.2014.7085 · Cited by 426
CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART
Fromentin, R., Bakeman, W., Lawani, M. B., Khoury, G., Hartogensis, W., DaFonseca, S., Killian, M., Epling, L., Hoh, R., Sinclair, E., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005761 · Cited by 422
T cells and viral persistence: lessons from diverse infections
Klenerman, P., & Hill, A. (2005) · Nature Immunology · doi:10.1038/ni1241 · Cited by 412
Structural and Functional Analysis of the Costimulatory Receptor Programmed Death-1
Zhang, X., Schwartz, J.-C. D., Guo, X., Bhatia, S., Cao, E., Chen, L., Zhang, Z.-Y., Edidin, M. A., Nathenson, S. G., & Almo, S. C. (2004) · Immunity · doi:10.1016/s1074-7613(04)00051-2 · Cited by 410
The immune response during hepatitis B virus infection
Bertoletti, A., & Gehring, A. J. (2006) · Journal of General Virology · doi:10.1099/vir.0.81920-0 · Cited by 385
Weiss, L., Donkova-Petrini, V., Caccavelli, L., Balbo, M., Carbonneil, C., & Levy, Y. (2004) · Blood · doi:10.1182/blood-2004-01-0365 · Cited by 384
Nakamoto, N., Cho, H., Shaked, A., Olthoff, K., Valiga, M. E., Kaminski, M., Gostick, E., Price, D. A., Freeman, G. J., Wherry, E. J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000313 · Cited by 380
Bengsch, B., Seigel, B., Ruhl, M., Timm, J., Kuntz, M., Blum, H. E., Pircher, H., & Thimme, R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000947 · Cited by 373
Inadequate T follicular cell help impairs B cell immunity during HIV infection
Cubas, R. A., Mudd, J. C., Savoye, A.-L., Perreau, M., van Grevenynghe, J., Metcalf, T., Connick, E., Meditz, A., Freeman, G. J., Abesada-Terk, G., et al. (2013) · Nature Medicine · doi:10.1038/nm.3109 · Cited by 371
Kalams, S. A., Buchbinder, S. P., Rosenberg, E. S., Billingsley, J. M., Colbert, D. S., Jones, N. G., Shea, A. K., Trocha, A. K., & Walker, B. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6715-6720.1999 · Cited by 369
Terawaki, S., Chikuma, S., Shibayama, S., Hayashi, T., Yoshida, T., Okazaki, T., & Honjo, T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003208 · Cited by 342
Programmed death-1 (PD-1)–deficient mice are extraordinarily sensitive to tuberculosis
Lázár-Molnár, E., Chen, B., Sweeney, K. A., Wang, E. J., Liu, W., Lin, J., Porcelli, S. A., Almo, S. C., Nathenson, S. G., & Jacobs, W. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007394107 · Cited by 338
CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1–Mediated Inhibition
Barber, D. L., Mayer-Barber, K. D., Feng, C. G., Sharpe, A. H., & Sher, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003304 · Cited by 329
Guignant, C., Lepape, A., Huang, X., Kherouf, H., Denis, L., Poitevin, F., Malcus, C., Chéron, A., Allaouchiche, B., Gueyffier, F., et al. (2011) · Critical Care · doi:10.1186/cc10112 · Cited by 325
Zhang, Y., Zhou, Y., Lou, J., Li, J., Bo, L., Zhu, K., Wan, X., Deng, X., & Cai, Z. (2010) · Critical Care · doi:10.1186/cc9354 · Cited by 308
Brahmamdam, P., Inoue, S., Unsinger, J., Chang, K. C., McDunn, J. E., & Hotchkiss, R. S. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0110037 · Cited by 305
Nakamoto, N., Kaplan, D. E., Coleclough, J., Li, Y., Valiga, M. E., Kaminski, M., Shaked, A., Olthoff, K., Gostick, E., Price, D. A., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.033 · Cited by 299
Bennett, F., Luxenberg, D., Ling, V., Wang, I.-M., Marquette, K., Lowe, D., Khan, N., Veldman, G., Jacobs, K. A., Valge-Archer, V. E., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.711 · Cited by 281
Pepper, M., Linehan, J. L., Pagán, A. J., Zell, T., Dileepan, T., Cleary, P. P., & Jenkins, M. K. (2010) · Nature Immunology · doi:10.1038/ni.1826 · Cited by 279
The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance
Schönrich, G., & Raftery, M. J. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00207 · Cited by 275
D’Souza, M., Fontenot, A. P., Mack, D. G., Lozupone, C., Dillon, S., Meditz, A., Wilson, C. C., Connick, E., & Palmer, B. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1979 · Cited by 260
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
Attanasio, J., & Wherry, E. J. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.022 · Cited by 256
Chen, H.-N., Wang, Z., Li, X., & Zhou, Z.-G. (2016) · Gastric Cancer · doi:10.1007/s10120-015-0462-7 · Cited by 254
Structure and Chromosomal Localization of the Human PD-1 Gene (PDCD1)
Shinohara, T., Taniwaki, M., Ishida, Y., Kawaichi, M., & Honjo, T. (1994) · Genomics · doi:10.1006/geno.1994.1562 · Cited by 253
Costimulation of T cells by OX40, 4-1BB, and CD27
Croft, M. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00025-x · Cited by 231
Gardiner, D., Lalezari, J., Lawitz, E., DiMicco, M., Ghalib, R., Reddy, K. R., Chang, K.-M., Sulkowski, M., Marro, S. O., Anderson, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063818 · Cited by 231
PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients
Peng, G., Li, S., Wu, W., Tan, X., Chen, Y., & Chen, Z. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.07.038 · Cited by 222
Fromentin, R., DaFonseca, S., Costiniuk, C. T., El-Far, M., Procopio, F. A., Hecht, F. M., Hoh, R., Deeks, S. G., Hazuda, D. J., Lewin, S. R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08798-7 · Cited by 212
Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice
Frebel, H., Nindl, V., Schuepbach, R. A., Braunschweiler, T., Richter, K., Vogel, J., Wagner, C. A., Loffing-Cueni, D., Kurrer, M., Ludewig, B., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20121015 · Cited by 209
PD-1 on dendritic cells impedes innate immunity against bacterial infection
Yao, S., Wang, S., Zhu, Y., Luo, L., Zhu, G., Flies, S., Xu, H., Ruff, W., Broadwater, M., Choi, I.-H., et al. (2009) · Blood · doi:10.1182/blood-2009-02-203141 · Cited by 208
Viral acute lower respiratory infections impair CD8+ T cells through PD-1
Erickson, J. J., Gilchuk, P., Hastings, A. K., Tollefson, S. J., Johnson, M., Downing, M. B., Boyd, K. L., Johnson, J. E., Kim, A. S., Joyce, S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62860 · Cited by 203
Holokai, L., Chakrabarti, J., Broda, T., Chang, J., Hawkins, J. A., Sundaram, N., Wroblewski, L. E., Peek, R. M., Wang, J., Helmrath, M., et al. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007468 · Cited by 189
Das, S., Suarez, G., Beswick, E. J., Sierra, J. C., Graham, D. Y., & Reyes, V. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3000 · Cited by 184
Unique human immune signature of Ebola virus disease in Guinea
Ruibal, P., Oestereich, L., Lüdtke, A., Becker-Ziaja, B., Wozniak, D. M., Kerber, R., Korva, M., Cabeza-Cabrerizo, M., Bore, J. A., Koundouno, F. R., et al. (2016) · Nature · doi:10.1038/nature17949 · Cited by 182
Inhibitors of the PD-1 Pathway in Tumor Therapy
LaFleur, M. W., Muroyama, Y., Drake, C. G., & Sharpe, A. H. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701044 · Cited by 175
Zhang, Z., Zhang, J., Wherry, E. J., Jin, B., Xu, B., Zou, Z., Zhang, S., Li, B., Wang, H., Wu, H., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.037 · Cited by 174
Esch, K. J., Juelsgaard, R., Martinez, P. A., Jones, D. E., & Petersen, C. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301810 · Cited by 166
Responsiveness of HIV-specific CD4 T cells to PD-1 blockade
Porichis, F., Kwon, D. S., Zupkosky, J., Tighe, D. P., McMullen, A., Brockman, M. A., Pavlik, D. F., Rodriguez-Garcia, M., Pereyra, F., Freeman, G. J., et al. (2011) · Blood · doi:10.1182/blood-2010-12-328070 · Cited by 164
Bhadra, R., Gigley, J. P., Weiss, L. M., & Khan, I. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015298108 · Cited by 163
Role of PD-1 in regulating acute infections
Brown, K. E., Freeman, G. J., Wherry, E. J., & Sharpe, A. H. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.03.007 · Cited by 160
Dong, Y., Li, X., Zhang, L., Zhu, Q., Chen, C., Bao, J., & Chen, Y. (2019) · BMC Immunology · doi:10.1186/s12865-019-0309-9 · Cited by 155
Rutebemberwa, A., Ray, S. C., Astemborski, J. A., Levine, J., Liu, L., Dowd, K. A., Clute, S. C., Wang, C., Korman, A. J., Sette, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8215 · Cited by 150
Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers
Sáez‐Cirión, A., Hamimi, C., Bergamaschi, A., David, A., Versmisse, P., Mélard, A., Boufassa, F., Barré‐Sinoussi, F., Lambotte, O., Rouzioux, C., et al. (2011) · Blood · doi:10.1182/blood-2010-12-327106 · Cited by 145
Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients
Tsunemi, S., Iwasaki, T., Imado, T., Higasa, S., Kakishita, E., Shirasaka, T., & Sano, H. (2005) · AIDS · doi:10.1097/01.aids.0000171401.23243.56 · Cited by 144
Srivastava, S., & Ernst, J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301236 · Cited by 137
Velu, V., Kannanganat, S., Ibegbu, C., Chennareddi, L. S., Villinger, F. J., Freeman, G. J., Ahmed, R., & Amara, R. R. (2007) · Journal of Virology · doi:10.1128/jvi.00024-07 · Cited by 134
Programmed Death-1 Controls T Cell Survival by Regulating Oxidative Metabolism
Tkachev, V., Goodell, S., Opipari, A. W., Hao, L.-Y., Franchi, L., Glick, G. D., Ferrara, J. L. M., & Byersdorfer, C. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402180 · Cited by 130
Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function
Sage, P. T., Schildberg, F. A., Sobel, R. A., Kuchroo, V. K., Freeman, G. J., & Sharpe, A. H. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701231 · Cited by 128
Self-citationAnastasopoulou, A. N., Ziogas, D. C., Samarkos, M., Kirkwood, J. M., & Gogas, H. J. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0717-7 · Cited by 128
Yang, J. D., Mott, D., Sutiwisesak, R., Lu, Y. J., Raso, F., Stowell, B. L., Babunovic, G. H., Lee, J., Carpenter, S. M., Way, S. S., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007060 · Cited by 114
X-Linked Syndrome of Polyendocrinopathy, Immune Dysfunction, and Diarrhea Maps to Xp11.23-Xq13.3
Bennett, C. L., Yoshioka, R., Kiyosawa, H., Barker, D. F., Fain, P. R., Shigeoka, A. O., & Chance, P. F. (2000) · The American Journal of Human Genetics · doi:10.1086/302761 · Cited by 112
Palmer, B. E., Neff, C. P., LeCureux, J., Ehler, A. C., D’Souza, M., Remling‐Mulder, L., Korman, A. J., Fontenot, A. P., & Akkina, R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201108 · Cited by 110
Karunarathne, D. S., Horne‐Debets, J. M., Huang, J. X., Faleiro, R. J., Leow, C. Y., Amante, F. H., Watkins, T. S., Miles, J. J., Dwyer, P., Stacey, K. J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.017 · Cited by 106
PD-1 Blockade in Chronically HIV-1-Infected Humanized Mice Suppresses Viral Loads
Seung, E., Dudek, T. E., Allen, T. M., Freeman, G. J., Luster, A. D., & Tager, A. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077780 · Cited by 102
Detrimental Contribution of the Immuno-Inhibitor B7-H1 to Rabies Virus Encephalitis
Lafon, M., Mégret, F., Meuth, S. G., Simon, O. J., Velandia-Romero, M. L., Lafage, M., Chen, L., Alexopoulou, L., Flavell, R. A., Prehaud, C. J. N., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7506 · Cited by 100
Wu, Y.-Y., Lin, C.-W., Cheng, K. S., Lin, C., Ym, W., Lin, I.-T., Chou, Y.-H., & Hsu, P.-N. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04217.x · Cited by 93
Yang, W., Li, H., Chen, P. W., ALIZADEH, H. M., He, Y.-G., Hogan, R. N., & Niederkorn, J. Y. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2397 · Cited by 92
Ha, S., Li, F., Troutman, M. C., Freed, D. C., Tang, A., Loughney, J. W., Wang, D., Wang, I., Vlasak, J., Nickle, D. C., et al. (2017) · Journal of Virology · doi:10.1128/jvi.02033-16 · Cited by 87
McNally, B. A., Ye, F., Willette, M., & Flaño, E. (2013) · Journal of Virology · doi:10.1128/jvi.02423-13 · Cited by 74
Anderson, K. M., Czinn, S. J., Redline, R. W., & Blanchard, T. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5306 · Cited by 70
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection
Agrati, C., Castilletti, C., Casetti, R., Sacchi, A., Falasca, L., Turchi, F., Tumino, N., Bordoni, V., Cimini, E., Viola, D., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.55 · Cited by 70
The Role of Coinhibitory Signaling Pathways in Transplantation and Tolerance
McGrath, M. M., & Najafian, N. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00047 · Cited by 67
Programmed Death 1 Regulates Development of Central Memory CD8 T Cells after Acute Viral Infection
Allie, S. R., Zhang, W., Fuse, S., & Usherwood, E. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003870 · Cited by 66
Niu, B., Zhou, F., Su, Y., Wang, L., Xu, Y., Yi, Z., Wu, Y., Du, H., & Ren, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01888 · Cited by 64
Habib, S., Andaloussi, A. E., Elmasry, K., Handoussa, A. E., Azab, M. S., Elsawey, A. M., Al-Hendy, A., & Ismail, N. (2018) · Infection and Immunity · doi:10.1128/iai.00019-18 · Cited by 63
Tessema, S. K., Utama, D., Chesnokov, O., Hodder, A. N., Lin, C. S., Harrison, G. L. A., Jespersen, J. S., Petersen, B., Tavul, L., Siba, P., et al. (2018) · Infection and Immunity · doi:10.1128/iai.00485-17 · Cited by 55
Checkpoint Inhibition and Infectious Diseases: A Good Thing?
Abers, M. S., Lionakis, M. S., & Kontoyiannis, D. P. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.08.004 · Cited by 55
A Rare Case of Pembrolizumab-Induced Reactivation of Hepatitis B
Pandey, A., Ezemenari, S., Liaukovich, M., Richard, I. N., & Avezbakiyev, B. (2018) · Case Reports in Oncological Medicine · doi:10.1155/2018/5985131 · Cited by 54
Peligero, C., Argilaguet, J. M., Güerri‐Fernández, R., Torres, B., Ligero, C., Colomer, P., Plana, M., Knobel, H., García, F., & Meyerhans, A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005270 · Cited by 50
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
Bucktrout, S. L., Bluestone, J. A., & Ramsdell, F. (2018) · Genome Medicine · doi:10.1186/s13073-018-0588-4 · Cited by 50
Role of Tim-3 in hepatitis B virus infection: An overview
Liu, Y., Gao, L., Liang, X., & Ma, C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i7.2294 · Cited by 46
Erickson, J. J., Rogers, M. C., Tollefson, S. J., Boyd, K. L., & Williams, J. V. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502115 · Cited by 46
Mou, Z., Muleme, H. M., Liu, D., Jia, P., Okwor, I., Kuriakose, S. M., Beverley, S. M., & Uzonna, J. E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202537 · Cited by 45
Tang, Z., Hao, Y.-H., Zhang, E., Xu, C., Zhou, Y., Zheng, X., & Yang, D. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5396 · Cited by 39
Nicholas, K. J., Zern, E. K., Barnett, L. D., Smith, R. M., Lorey, S. L., Copeland, C. A., Sadagopal, S., & Kalams, S. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084185 · Cited by 37
Teigler, J. E., Zelinskyy, G., Eller, M. A., Bolton, D. L., Marovich, M., Gordon, A. D., Alrubayyi, A., Alter, G., Robb, M. L., Martin, J. N., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01263-17 · Cited by 37
Shen, L., Shi, H., Gao, Y., Ou, Q., Liu, Q., Liu, Y., Wu, J., Zhang, W., Fan, L., & Shao, L. (2016) · Tuberculosis · doi:10.1016/j.tube.2016.10.001 · Cited by 35
Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C
Larrubia, J. R., Martínez, S. B., Miquel, J., Calvino, M., Sanz‐de‐Villalobos, E., & Parra-Cid, T. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5129 · Cited by 33
Programmed death-1 expression is associated with the disease status in hepatitis B virus infection
Ye, P., Weng, Z., Zhang, S., Zhang, J.-A., Zhao, L., Dong, J.-H., Jie, S., Pang, R., & Wei, R.-H. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4551 · Cited by 29
Fonseca, R., Salgado, R. M., da Silva, H. B., do Nascimento, R. S., Lima, M. R. D., & Álvarez, J. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00997 · Cited by 23
Role of PD-L1/PD-1 in the immune response to respiratory viral infections
Zdrenghea, M., & Johnston, S. L. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.01.002 · Cited by 19
Phenotypic Characteristics of PD-1 and CTLA-4 Expression in Symptomatic Acute Hepatitis A
Cho, H., Kang, H., Kim, C. W., Kim, H. Y., Jang, J. W., Yoon, S. K., & Lee, C. D. (2015) · Gut and Liver · doi:10.5009/gnl14368 · Cited by 18
Muema, D., Macharia, G. N., Olusola, B. A., Hassan, A. S., Fegan, G., Berkley, J. A., Urban, B. C., & Nduati, E. W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175570 · Cited by 16
Cortés, K. C., Osuch, S., Perlejewski, K., Pawełczyk, A., Kaźmierczak, J., Janiak, M., Jabłońska, J., Nazzal, K., Stelmaszczyk‐Emmel, A., Berak, H., et al. (2019) · Journal of Viral Hepatitis · doi:10.1111/jvh.13108 · Cited by 16
Cited by
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Korman, A. J., Garrett-Thomson, S. C., & Lonberg, N. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00345-8 · Cited by 548
Wu, M., Huang, Q., Xie, Y., Wu, X., Ma, H., Zhang, Y., & Xia, Y. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01242-2 · Cited by 456
Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
Gumber, D., & Wang, L. D. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.103941 · Cited by 396
Persistent cellular immunity to SARS-CoV-2 infection
Breton, G., Mendoza, P., Hägglöf, T., Oliveira, T. Y., Schaefer-Babajew, D., Gaebler, C., Turroja, M., Hurley, A., Caskey, M., & Nussenzweig, M. C. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202515 · Cited by 129
Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
Cai, X., Zhan, H., Ye, Y., Yang, J., Zhang, M., Li, J., & Zhuang, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.785153 · Cited by 66
Metadata
- Authors
- Jubel, J. M., Barbati, Z. R., Burger, C., Wirtz, D. C., & Schildberg, F. A.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-03-24
- Volume
- 11
- Pages
- 487-487
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3014004967
- Cited by
- 307
- References
- 124
- FWCI
- 12.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.